Clinical trial BSMO 2014 01
A prospective, Belgian multi-center, single-arm, phase II study of neoadjuvant weekly paclitaxel and carboplatin followed by dose dense epirubicin and cyclophosphamide in stage II and III triple negative breast cancer
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Oui |
Sponsor | UZ-Brussel |
EudraCT Identifier | 2014-003723-21 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04224922 |
Inclusion criteria | TNBC |
Last update |